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Through the use of a keratinocyte/ﬁbroblast co-culture system, we have recently identiﬁed a potent keratinocyte-
derived anti-ﬁbrogenic factor (KDAF) for dermal ﬁbroblasts. A sequential chromatography of the active fractions of
keratinocyte-conditioned medium (KCM) and peptide mapping of the candidate proteins identiﬁed KDAF as being
the keratinocyte-releasable 14-3-3 sigma (14-3-3r) protein, which is also known as stratiﬁn. In this study, we
hypothesize that differentiated, but not proliferating, keratinocytes are the primary source of releasable 14-3-3r in
conditioned medium. To address this hypothesis, in a longitudinal study, keratinocyte differentiation was induced
by growing these cells in a medium consisting of 50% keratinocyte serum-free medium (KSFM) and 50% Dulbecco’s
modiﬁed eagle’s medium without any additives for up to 20 d. When KCM was collected every other day and added
to ﬁbroblasts, the level of matrix metalloproteinase (MMP)-1 mRNA expression was markedly increased in ﬁbro-
blasts receiving KCM and this increase was even greater in cells receiving conditioned media collected at later time
points relative to that of controls. The results of a western blot analysis further showed a marked increase in the
expression of 14-3-3r protein in keratinocytes grown in test medium from day 4 to day 10. This ﬁnding was
consistent with the levels of 14-3-3r mRNA expression in differentiated keratinocytes. In contrast to a very high
level of 14-3-3r mRNA expression seen in keratinocytes, ﬁbroblasts that are highly responsive to14-3-3r were
unable to express this factor. Interestingly, the level of 14-3-3r mRNA expression was markedly higher in kera-
tinocytes co-cultured with ﬁbroblasts relative to that of mono-cultured keratinocytes. In conclusion, this study
provides evidence that keratinocytes express a high level of 14-3-3r at the levels of mRNA and protein. But the
releasable form of 14-3-3r protein was only found in conditioned medium derived from differentiated keratinocytes.
Further, our recently puriﬁed recombinant 14-3-3r protein mimics the collagenase stimulatory effect of KCM in
dermal ﬁbroblasts.
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The ability to generate or repair injured tissue is essential to
the continuity of human life (Scott et al, 1994). Epidermal–
mesenchymal communication is critical in exchanging the
information between keratinocytes and fibroblasts in skin
morphogenesis during development and probably in main-
taining the integumentary structure in the adult (reviewed in
Johnson-wint, 1980). It is also well established that any de-
lay in epithelialization, due to either infection or severity of
injury, increases the frequency of developing fibrotic con-
ditions. This is based on the fact that when keratinocytes
form epithelialization on the wound within 2–3 wk, only one-
third of the anatomically site-matched wounds become
hypertrophic, whereas this increases to 78% when a wound
is epithelialized later than 21 d. This signifies that in the
absence of epithelialization, extracellular matrix (ECM)
continues to accumulate until dermal fibroblasts receive
signal(s) from epidermal cells to slow down the dynamic
process of healing that leads to maturation and remodeling
of the healing wound (Machesney et al, 1998). We have
recently conducted a series of experiments to test our
working hypothesis that a keratinocyte-derived anti-
fibrogenic factor (s) (KDAF) might function as a wound-
healing stopping signal (s) by modulating the expression of
key extracellular proteins such as collagenase (matrix
metalloproteinase (MMP)-1) and possibly collagen type I
and type III in dermal fibroblasts. As previously reported
(Ghahary et al, 2004), a sequential chromatography of the
keratinocyte-conditioned medium (KCM), peptide mapping,
and amino acid sequencing of purified KDAF turned out to
be a keratinocyte-releasable 14-3-3 sigma (14-3-3s) protein
also known as stratifin.
Stratifin is a member of a large family of highly con-
served, acidic dimeric 14-3-3 proteins. Although several
members of the protein family appear to be ubiquitous-
ly expressed, as reported by Leffers et al (1993), stratifin
expression seems to be specific to stratified epithelial
cells. These investigators used 2D gel electrophoresis
Abbreviations: KCM, kerationocyte-conditioned medium; KDAF,
kerationocyte-derived anti-fibrogenic factor; KSFM, keratinocyte
serum-free medium; 14-3-3 sigma, 14-3-3s
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and identified several members of this protein family in
keratinocytes. Immunofluorescence staining of keratin-
ocytes localized two members of these proteins to the Go-
lgi apparatus, whereas stratifin was distributed diffusely in
the cytoplasm. These investigators also found a significant
level of stratifin in the medium of cultured human keratin-
ocytes, suggesting a partial secretion of this protein by
keratinocytes. Isolation and identification of stratifin as an
intracellular keratinocyte-derived stimulator of protein kin-
ase C-mediated phosphorylation has also been reported
(Dellambra et al, 1995). In another study, Katz and Taichman
(1999) also identified epsilon and sigma forms of protein 14-
3-3 in KCM.
Although many functional activities have been described
for the intracellular members of this protein family, biological
roles of the releasable forms of the members of the 14-3-3
protein family in general and 14-3-3s in particular are com-
pletely unknown. Our previous study identified and charac-
terized a KDAF for dermal fibroblasts, which surprisingly
turned out to be a releasable form of 14-3-3s protein. In this
study, we have established a keratinocyte/fibroblast co-
culture system and showed that our purified recombinant
14-3-3s protein mimics the collagenase stimulatory effect
of KDAF for dermal fiboblasts. We further demonstrated an
increase in 14-3-3s at the levels of mRNA and intracellular
protein expression as well as in the releasable form of this
protein in differentiated keratinocytes. Interestingly, fibro-
blasts that were highly responsive to 14-3-3s failed to ex-
press 14-3-3s mRNA. Thus, fibroblasts might be the main
target for the keratinocyte-releasable 14-3-3s protein.
Results
Co-culturing keratinocytes with ﬁbroblasts increases
the expression of MMP-1 mRNA in ﬁbroblasts In order to
identify a KDAF for dermal fibroblasts, we recently estab-
lished a keratinocyte/fibroblast co-culture system in which
keratinocytes and fibroblasts are grown in the upper and
lower chambers of this system, respectively. A test medium
consisting of 49% keratinocyte serum-free medium (KSFM),
49% Dulbecco’s modified Eagle’s medium (DMEM), and
2% fetal bovine serum (FBS), which was suitable for both
keratinocytes and fibroblasts, was used. As a permeable
membrane separates these cells, fibroblasts in the lower
chamber can be exposed to any factor released from the
keratinocytes. As an index for the anti-fibrogenic effects of
keratinocyte-derived factor(s) on dermal fibroblasts, total
RNA was extracted from fibroblasts grown in the lower
chamber and the expression of MMP-1 mRNA was evalu-
ated by northern analysis. Fibroblasts grown alone and fib-
roblasts grown in a fibroblast/fibroblast co-culture system
were also used as controls. As shown in Fig 1A, MMP-1
mRNA expression is significantly increased in fibroblasts (F/
K) as early as 12 h post-co-culturing with keratinocytes rel-
ative to fibroblasts grown in fibroblast/fibroblast (lane F/F)
co-culture system. The level of MMP-1 mRNA expression
remained high up to 72 h examined. To determine whether
this factor is specific to keratinocytes and that it is still re-
leasable from keratinocytes grown in a mono-culture sys-
tem, conditioned media from two different strains of human
keratinocyte (K1 and K2) and fibroblasts (F1 and F2) were
collected and fractionated by a 30 kDa cut-off filter of
the Centricon Tubes (Millipore, Bedford, Massachusetts).
The portions of unfiltered material (C), filtrate (F), and re-
tentate (R) were individually added to fibroblasts for 24 h
and the efficacy of any releasable factors on MMP-1 mRNA
expression was evaluated by northern analysis. As shown in
Fig 1B, MMP-1 stimulating activity was only found in the
unfiltered KCM (lane C) and retentate (lane R). But neither
the filtrate (lane F) of KCM nor any fraction of fibroblast-
conditioned medium was able to stimulate the expression of
MMP-1 mRNA. MMP-1 stimulatory effect of KDAF was not
due to RNA loading as the pattern of 18S ribosomal RNA
was relatively the same in all samples (Fig 1C). These find-
ings collectively suggest that the size of this protein is about
or greater than 30 kDa and the release of this factor is spe-
cific to keratinocytes, but not fibroblasts, grown in either a
mono- or co-culture system.
14-3-3r protein mimics the effect of KDAF on collagen-
ase mRNA expression in ﬁbroblasts After having previ-
ously demonstrated that KDAF for dermal fibroblasts is in
fact the same as stratifin (14-3-3s protein), here we exam-
ined the efficacy and the lasting effect of our human re-
combinant 14-3-3s on collagenase mRNA expression in
fibroblasts. The recombinant 14-3-3s protein produced in
bacteria was more than 95% pure (Ghahary et al, 2004).
To evaluate the efficacy of recombinant 14-3-3s on the
Figure1
Keratinocyte-conditioned medium (KCM) increases collagenase
mRNA expression in dermal fibroblasts. Total RNA from either fib-
roblasts (F/F) or fibroblasts (F/K) co-cultured with keratinocytes for dif-
ferent time points was extracted and used to evaluate the expression of
collagenase mRNA by northern analysis (panel A). In panel B, two dif-
ferent strains of keratinocytes (K1 and K2) and fibroblasts (FI and F2)
were cultured individually and their conditioned media were collected
and passed through a Centricon filter with a 30 kDa cut-off. Fibroblasts
were then treated with either unfiltrated whole conditioned medium (C),
the corresponding filtrate (F), or retentate (R) for 24 h. Cells were then
harvested and extracted RNA was used to evaluate the expression of
collagenase mRNA by northern analysis. Panel C shows the pattern of
18S and 28S ethidium bromide-stained ribosomal RNA used as a
loading control of the same blot seen in panel B.
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expression of MMP-1 in dermal fibroblasts, cells were
treated with either nothing or various concentrations of re-
combinant 14-3-3s (0.25, 0.5, 1.0, and 2.5 mg per mL) for
24 h (Fig 2A). The results showed a marked increase in the
expression of collagenase mRNA in treated fibroblasts. This
increase reached its maximum with 0.5–1.0 mg per mL of
14-3-3s used. In another experiment, the lasting effect of
14-3-3s in collagenase expression was evaluated. The re-
sults again showed a marked increase in expression of
collagenase mRNA in treated dermal fibroblasts relative to
that of the control. When the 14-3-3s protein was removed
from the culture medium, the level of collagenase mRNA
expression remained high up to 6 h and then gradually re-
duced to its normal value within 36 h of 14-3-3s removal
(Fig 2B).
The level of 14-3-3r protein is greater in differentiated
keratinocyte-conditioned medium To address the ques-
tion of whether differentiated or proliferating keratinocytes
release the 14-3-3s protein, conditioned medium from pro-
liferating keratinocytes grown in KSFM was replaced with
test medium in which keratinocytes in the presence of high
calcium levels gradually become differentiated. Cells and
conditioned medium from day 0, 2, 4, 6, 8, and 10 were then
collected and evaluated for intra- and extracellular levels of
14-3-3s protein by western blot analysis. The level of in-
tracellular 14-3-3s protein was easily detectable in keratin-
ocytes harvested in all time points. The expression of this
protein was, however, markedly increased in keratinocytes
grown in test medium for 6, 8, and 10 d (Fig 3A). This in-
crease was not due to protein loading as the amount of
intracellular b-actin protein was not increased by differen-
tiation (Fig 3B). When the levels of 14-3-3s protein were
evaluated in the corresponding conditioned media, the re-
leasable form of this protein was only found in conditioned
medium collected on day 6, 8, and 10 (Fig 3C). To confirm
this finding, in another set of experiments, the level of 14-3-
3s mRNA expression in keratinocytes grown in test medium
for 0, 1, 2, 3, 4, 5, 14, 18, and 20 d was evaluated by
northern analysis. The results showed a very high level of
14-3-3s mRNA expression in keratinocytes harvested at all
time points. But this expression was higher at early and late
time points (Fig 4, panel A). To correlate this expression with
the differentiation status of keratinocytes, the same blot
was rehybridized with cDNA specific for involucrin, which is
known as one of the differentiation markers for keratin-
ocytes. The expression of this marker was very high on day
14, 18, and 20 examined. A very faint detectable band of
involucrin mRNA was also found in keratinocytes harvested
on day 5. In a similar longitudinal experimental setting, ker-
atinocytes conditioned media collected at various time in-
tervals were evaluated for their collagenase stimulatory
effects in dermal fibroblasts by northern analysis. The re-
sults showed that all samples of KCM added to dermal
fibroblasts for 24 h possess a very high collagenase
stimulatory effects (Fig 4, panel B, day 2–20). Consistent
with the levels of 14-3-3s mRNA expression in differenti-
ated keratinocytes (later time points), the conditioned media
collected at later time points showed a higher collagenase
stimulatory effect in dermal fibroblasts. The absence of
any collagenase stimulatory effect seen in fibroblasts,
which received either fresh medium (C) or conditioned
medium collected from proliferating keratinocytes grown in
KSFMþbovine pitutary extract (BPE) and epidermal growth
Figure 2
Recombinant 14-3-3 sigma (14-3-3r) protein increases the expres-
sion of collagenase mRNA in dermal fibroblasts. Cells were treated
with either nothing (C) or various concentrations (0.25, 0.5, 1.0, and
2.5 mg per mL) of our recombinant 14-3-3s for 24 h and the expression
of collagenase mRNA and 18S ribosomal RNA (loading control) was
assessed by Northern analysis (panel A). To determine the lasting effect
of 14-3-3s on collagenase expression, fibroblasts were treated with
either nothing (C) or 2.5 mg per mL of 14-3-3s for 24 h. The medium
was replaced with fresh medium without 14-3-3s and cells were then
harvested at 0, 3, 6, 12, 24, 36, 48, and 72 h post 14-3-3s removal. The
expression of collagenase mRNA in dermal fibroblasts was then eval-
uated by northern analysis. The pattern of 18S ribosomal RNA is also
shown as a loading control.
Figure3
Differentiated keratinocytes release a greater level of 14-3-3 sigma
(14-3-3r) into conditioned medium. To evaluate intra- and extracel-
lular forms of 14-3-3s protein in differentiated keratinocytes, cells
(0.5  106 cells per well) were grown in keratinocyte serum-free me-
dium (KSFM) for 48 h and conditioned medium was replaced with test
medium. The protein contents of conditioned media collected on day 0,
2, 4, 6, 8, and 10 and corresponding cell extracts were determined by
western blot analysis. Panels A and B show the patterns of intracellular
form 14-3-3s and b-actin, respectively. The pattern of the releasable
form of 14-3-3s is shown in panel C.
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factor (EGF) (lane P), suggests that proliferating keratin-
ocytes may express 14-3-3s mRNA (Fig 4A, 0 time point)
but that it may not be releasable (Fig 3C) in sufficient
amount to stimulate the collagenase expression in dermal
fibroblasts (Fig 4B). Further, an addition of 14-3-3s at a final
concentration of 1 mg per mL (lane K) into fresh medium
added to fibroblasts seems to mimic the collagenase
stimulatory effect of KCM in fibroblasts.
To further demonstrate that differentiated keratinocytes
express stratifin and that it is correlated with involucrin, a
microscopic phase contrast evaluation of keratinocytes as
well as an immunohistochemical staining for these proteins
were conducted. As shown by the phase contrast appear-
ance of keratinocytes grown in test medium to induce dif-
ferentiation on day 5 (Fig 5A) and 9 (Fig 5B), keratinocytes
began to form some areas of non-uniformity on day 5 and
this changed to form multilayer nodules on day 9. We have
found one to three keratinocyte multilayer forming nodules
with different sizes in each microscopic field. The results of
immunohistochemical staining for stratifin and involucrin
showed very high levels of stratifin and involucrin in cultured
keratinocytes on day 9 (Fig 5C and D, respectively), but not
day 5 (data not shown), at which keratinocytes become
differentiated and form multilayers in culture (Fig 5G and H).
This staining was only seen on the areas that keratinocytes
form multilayer nodules.
Dermal ﬁbroblasts co-cultured with keratinocytes fail to
express 14-3-3r mRNA As the level of MMP-1 mRNA ex-
pression is markedly increased in response to both KCM
and recombinant 14-3-3s, we investigated whether fibro-
blasts are merely targets for the keratinocyte-releasable 14-
3-3s protein or whether they have ability to produce this
protein. This question was addressed by growing dermal
fibroblasts alone or in a keratinocyte co-culture system.
Figure 4
Time-dependent expression of 14-3-3 sigma (14-3-3r) and in-
volucrin mRNA in keratinocytes. Keratinocytes were cultured in ker-
atinocyte serum-free medium (KSFM) for 48 h and medium was
replaced with test medium. Keratinocytes were then harvested on day
0, 1, 2, 3, 4, 5, 14, 18, and 20. Total RNA was extracted and analyzed by
northern analysis. The blot was initially hybridized with cDNA specific
for 14-3-3s and subsequently with cDNA for involucrin and 18S rib-
osomal RNA used as a control for RNA loading (panel A). In another set
of experiments, keratinocytes were cultured in KSFM for 48 h and me-
dium was replaced with test medium. The conditioned media collected
every 48 h up to 20 d were then used to treat fibroblasts for 24 h (day 2–
20). Panel B, total RNA from cells that received either fresh medium (C),
fresh medium plus 1 mg per mL of 14-3-3s protein (K), keratinocyte-
conditioned medium (KCM) collected at different days (day 2–20), or
conditioned medium from proliferating keratinocyte grown in KSFM
plus additive for 48 h (P). The RNA was extracted and analyzed for
collagenase mRNA expression. The blot was subsequently re-hybrid-
ized with cDNA specific for 18S ribosomal RNA and used as a RNA
loading control.
Figure5
Immunohistochemical detection of 14-3-3 sigma (14-3-3r) and in-
volucrin in cultured keratinocytes. Panels A and B show the phase
contrast microscopic appearance of keratinocytes grown in test me-
dium to induce differentiation on day 5 (A) and day 9 (B). Scale
bar¼200 mm. Panels C and D show the low magnification of 14-3-3s
(panel C) and involucrin (panel D) of cultured keratinocytes on day 9.
Scale bar¼ 500 mm, whereas panels E–H represent a high magnifica-
tion of corresponding areas related to the red (panels E and F) and
green (panels G and H) rectangular insets shown in panels C and D.
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Both keratinocytes and fibroblasts were separately harvest-
ed and total RNA was extracted and evaluated for 14-3-3s
and collagenase mRNA expression. The results shown in
Fig 6 clearly demonstrate that fibroblasts co-cultured with
keratinocytes expressed a very high level of collagenase
mRNA (lane F/K) relative to that of fibroblasts cultured alone
(lane F). This finding again confirms that keratinocytes re-
lease a very potent collagenase-stimulating factor for der-
mal fibroblasts. When the same blot was re-hybridized with
14-3-3s cDNA, under both mono- and co-culture condi-
tions, keratinocytes expressed a very high level of 14-3-3s
mRNA. On the other hand, our findings demonstrate that
fibroblasts grown alone or in the presence of keratinocytes
are unable to express a detectable level of mRNA for 14-3-
3s. Interestingly, keratinocytes co-cultured with dermal fib-
roblasts seem to express greater levels of 14-3-3s mRNA
relative to those cultured alone. This may indicate that
fibroblast-releasable factors stimulate the expression of
14-3-3s in keratinocytes. We also found that growing
keratinocytes on a collagen-coated filter in the top cham-
ber stimulates the expression of collagenase mRNA by
these cells relative to those grown on plastic (data not
shown). The same blot was finally re-hybridized with cDNA
specific for 18S ribosomal RNA and was used as a total
RNA loading control (Fig 6B).
Discussion
In this study, we demonstrated that the expression of 14-3-
3s mRNA and intracellular protein is detectable in both
proliferating and differentiated keratinocytes; however, Only
differentiated keratinocytes were able to release 14-3-3s
protein into conditioned medium. We also demonstrated
that our recombinant 14-3-3s protein mimics the collagen-
ase-stimulating effect of KCM in dermal fibroblasts. This
finding was confirmed by another experiment revealing that
the presence of 14-3-3s in culture medium is needed for
expression of MMP-1 mRNA in fibroblasts. This is because
removal of 14-3-3s from the fibroblast-conditioned medium
reduces the expression of collagenase to its normal value
within 36 h.
14-3-3 proteins are a class of highly conserved molecular
chaperones. They are a ubiquitous family of acidic eukaryo-
tic proteins with seven known mammalian isoforms, a/b, g,
e, p, s, t(y), and z (Martens et al, 1992). Since the discovery
of the first 14-3-3 protein (Moore and Perez, 1967) with an
unknown function in the brain, the members of the 14-3-3
protein family have been repeatedly re-discovered based on
new biological activities, primarily in the context of signal
transduction pathways. They have been identified as acti-
vators of tryptophan and tyrosine hydroxylase (Ichimura
et al, 1987; Ichimura et al, 1988) and protein kinase C (PKC)
inhibitors (Toker et al, 1990). Subsequent studies identified
the 14-3-3 proteins as molecules that interact with PKC, Raf
family members. It is now known that more than 100 other
intracellular proteins with critical biological functions includ-
ing cellular response to DNA damage and cell cycle regu-
lation interact with 14-3-3 proteins (Craparo et al, 1997;
Hermeking et al, 1997; Chan et al, 2000; Laronga et al,
2000; Yaffe 2002). It should be emphasized that among all
members of the protein 14-3-3 family, the s form is reported
to be vital in preventing mitotic catastrophe after DNA
damage (Chan et al, 1999).
Further, some soluable forms of 14-3-3 protein have
been shown to be present in the cerebrospinal fluid (CSF)
and has been associated with prion diseases such as
Creutzfeldt–Jakob disease and other neurological disorders
(Boston et al, 1982; Satoh et al, 1999). But no biological
functions of these soluble forms of 14-3-3 proteins have so
far been described. Thus, the collagenase-stimulating ac-
tivity of keratinocyte-releasable 14-3-3s for dermal fibro-
blasts considered to be the first indication of a relevant
extracellular biological function of keratinocyte-releasable
stratifin.
As mentioned above, 14-3-3 proteins are considered to
be intracellular proteins with many critical biological activ-
ities. It is therefore assumed that these proteins lack known
amino-terminal endoplasmic reticulum (ER) signal peptides
and, as such, the mechanism by which these proteins be-
come releasable has yet to be elucidated. There is now
supporting evidence to indicate that this is not unique to 14-
3-3 proteins as there are several well-known releasable
proteins, such as interleukin (IL)-1 (Andree et al, 1992; Co-
rradi et al, 1995), fibroblast growth factor-2 (Albuquerque
et al, 1998), and endothelial cell growth factor (Jaye et al,
1986), which lack signal peptides and yet are considered to
be releasable proteins. In an earlier report, we found a se-
creted form of annexin II in KCM (Karimi-Busheri et al, 2002)
and at that time we assayed for the presence of lactate
dehydrogenase (LDH) in the medium, as a marker of cell
lysis (Korzeniewski and Callewaert, 1983; Decker and Loh-
mann-Matthes, 1988), and established that the release of
this protein into the media was not the result of keratinocyte
lysis. Since the same batches of KCM were used in both
Figure 6
Expression of 14-3-3 sigma (14-3-3r) mRNA in keratinocytes cor-
relates with collagenase mRNA expression in dermal fibroblasts
grown in a co-culture system. To demonstrate the expression of 14-
3-3s mRNA in keratinocytes (K/F) and correlate that with collagenase
expression in dermal fibroblasts (F/K), a keratinocyte/fibroblast co-cul-
ture system was established. Cells were then individually harvested
and the expression of 14-3-3s and collagenase mRNA detected by
northern analysis was compared with those of cells grown in a mono-
culture system (panel A). The pattern of 18S ribosomal RNA obtained
from re-hybridization of the same blot used as an RNA loading control
(panel B).
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studies, we can rule out cell lysis as the cause for release of
14-3-3s into the KCM. Furthermore, accidental release of
14-3-3 would also be unlikely due to the fact that recom-
binant KDAF mimics the MMP-1 stimulatory function of
KDAF found in KCM.
Since overexpression of MMP has been implicated with
non-healing wound conditions, one may speculate that the
release of KDAF and the subsequent stimulation of MMP-1
in dermal fibroblasts cause wound healing retardation. The
result of our longitudinal experiments revealed that this is
unlikely to be the case. This is because only differentiated,
but not proliferating, keratinocytes release a sufficient
amount of 14-3-3s protein to stimulate collagenase ex-
pression in fibroblasts. Differentiation of keratinocytes
was induced by growing these cells in test medium that
contained relatively high levels of calcium in which kera-
tinocytes undergo differentiation and expressed a differen-
tiation marker such as involucrin. This finding was further
supported by an immunohistochemical staining for in-
volucrin and 14-3-3s in cultured keratinocytes grown in
test medium. The results showed that on day 9, but not day
5, at which keratinocytes become differentiated and form
multilayer in culture express high levels of 14-3-3 protein as
well as involucrin. This staining was only seen on the areas
that keratinocytes form multilayers.
It is of interest to mention that keratinocytes co-cultured
with dermal fibroblasts seem to express a greater level of
mRNA for 14-3-3s relative to those grown in a mono-culture
condition. This finding may indicate that fibroblasts release
a 14-3-3s stimulating factor, whereas keratinocytes release
the 14-3-3s, which stimulates the expression of collagen-
ase in dermal fibroblasts. Further, it seems that growing
keratinocytes on a collagen-coated filter stimulates the ex-
pression of collagenase mRNA by these cells relative to
those grown on plastic. This seems to be true for fibroblasts
as well. Moreover, our unpublished data showed that fib-
roblasts grown in a 3D collagen gel express greater levels of
collagenase relative to those grown on plastic (data not
shown). These findings collectively indicate that at early
stages of the healing process, proliferating and migrating
keratinocytes express a high level of ECM deposition fac-
tors (Ghahary et al, 2001), whereas at a later stage of heal-
ing, when epithelialization is complete, the multi-layer form
of differentiated keratinocytes releases some ECM degra-
dation factors such as 14-3-3s and possibly other members
of this protein family. Thus, upon epithelialization and ker-
atinocyte differentiation, this complementary mechanism
would then slow down or even terminate the dynamic proc-
ess of healing.
It is well established that MMP-1 is expressed by several
types of malignant cells. This enzyme is one of the few
proteolytic enzymes that is able to degrade native fibrillar
collagens. As such, an increase in MMP-1 expression is
correlated with a prognosis of malignant tumors, including
gastric and colon carcinomas (Murray et al, 1996; Inoue
et al, 1999). On the other hand, malignant cells may release
some factors influencing the expression of MMP-1 in neigh-
boring cells. Westermarck et al (2002) demonstrated that a
subgroup of low passage primary tumor cells established
from head and neck squamous cell carcinoma (SCC) re-
leases some soluble factors that induce MMP-1 expression
in normal and tumor fibroblasts. Although these investiga-
tors were not able to identify the nature of these collagen-
olytic phenotype-inducing factors in conditioned medium,
they showed that collagenase-stimulating factors such as
tumor necrosis factor-a and IL-1b are not the only factors
responsible for these effects. Although it is not known
whether stratifin is one of these SCC-releasable factors that
increases collagenase expression in fibroblasts, our unpub-
lished data suggest that SCC, at least at the level of mRNA,
express stratifin at relatively a high level. We are currently
examining whether this factor is releasable and if so, it
remains to be seen whether it influences the expression of
collagenase in fibroblasts.
In conclusion, the findings of this study collectively pro-
vide compelling evidence that differentiated keratinocytes
release collagenase-stimulatory 14-3-3s protein for dermal
fibroblasts and that this may in turn control degradation of
the major dermal ECM components such as type I and type
III procollagen. The keratinocyte secreted 14-3-3 proteins
or their fibroblast receptors may provide useful targets for
clinical intervention in the control of wound healing and the
development of fibrosis.
Materials and Methods
Clinical specimens and cell culture Following informed consent,
skin punch biopsies were obtained from patients undergoing elec-
tive reconstructive surgery, under local anesthesia, according to a
protocol approved by the University of Alberta Hospitals Human
Ethics Committee. The study was carried out in accordance with
the principles of the Declaration of Helsinki, (World Medical
Association of Helsinki, Somerset West, 1996). Biopsies were col-
lected individually and washed three times in sterile DMEM (Gibco,
Grand Island, New York) supplemented with antibiotic–antimycotic
preparation (100 mg per mL penicillin, 100 mg per mL streptomycin,
0.25 mg per mL amphotericin B) (Gibco). Cultures of fibroblasts
were established as previously described (Karimi-Busheri et al,
2002). Upon reaching confluence, the cells were released by try-
psinization, split for subculture at a ratio of 1:6, and reseeded into
75 cm2 flasks. Fibroblasts at passages 3–8 were used in either
mono- or co-culture system.
To establish cultured keratinocytes, the procedure of Rheinwald
and Green (1975) was used for cultivation of human foreskin ker-
atinocytes using KSFM (Gibco) supplemented with BPE (50 mg per
mL) and EGF (5 mg per mL). Primary cultured keratinocytes at
passages 3–5 were used.
Keratinocyte–ﬁbroblast co-culture system In order to identify
a KDAF for dermal fibroblasts, we had previously established
(Karimi-Busheri et al, 2002; Ghahary et al, 2004) a keratinocyte/
fibroblast co-culture system in which keratinocytes and fibroblasts
are grown in the upper and lower chambers of the system, re-
spectively. For the co-culture experiments, 30 mm Millicell-CM
(Millipore) culture plate inserts with 0.4 mm pore size were coated
with fetal bovine skin collagen (3 mg per mL). Subsequently,
0.5  106 keratinocytes were seeded on the collagen-coated in-
serts with KSFM supplemented with BPE (50 mg per mL) and EGF
(5 mg per mL). In a separate experiment, 0.5  106 fibroblasts were
seeded in each well of a six-well culture plate containing DMEM
with 10% FBS. The cells were incubated in a cell culture incubator
for 24 h and the conditioned medium was collected and cells were
washed with phosphate-buffered saline (PBS). The co-culture sys-
tem was then assembled, with the upper chamber being the col-
lagen-coated insert with keratinocytes and the bottom chamber
being the fibroblasts grown on a plastic six-well plate. The controls
were inserts either alone, with keratinocytes, or with fibroblasts.
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Each chamber received 2.5 mL of our test medium consisting
of 49% KSFM without additive and 49% DMEM plus 2% FBS. As
only a permeable membrane separates these cells, fibroblasts in
the lower chamber can be exposed to any soluble factor that may
be released from keratinocytes. As an index for the anti-fibrogenic
effects of keratinocyte-derived factor(s) on dermal fibroblasts, total
RNA was extracted from fibroblasts grown in the lower chamber
and the expression of collagenase mRNA was evaluated by north-
ern analysis.
Extraction of cellular RNA and northern analysis Keratinocytes
and fibroblasts grown in either a mono- or co-culture system were
harvested separately and pelleted by centrifugation at 300  g for
10 min. Pellets were then lysed with 500 mL of 4 M guanidium
isothiocyanate (GITC) solution and total RNA was isolated by the
guanidium isothiocyanate/CsCl procedure of Chomczynski and
Sacchi (1987) using phenol:chloroform (1:1), followed by chloro-
form:isoamyl alcohol (49:1). Total RNA from each individual fibro-
blast culture was then separated by electrophoresis (10 mg per
lane) on a 1% agarose gel and blotted onto nitrocellulose filters.
Filters were then baked under vacuum for 2 h at 801C, pre-hy-
bridized and hybridized according to the procedure described be-
fore (Ghahary et al, 2004). Hybridization was performed in the
same solution at 451C for 16–20 h using cDNA probes for either
human MMP-1, 14-3-3s, or 18S ribosomal RNA. The probes were
labeled with 32P-a-dCTP (DuPont Canada, Streetsville, Mississ-
auga, Ontario, Canada) by nick-translation. Filters were initially
washed at room temperature with 2  SSC (1  ¼ 0.15 M sodium
chloride, 0.015 M sodium citrate) and 0.1% SDS for 30 min, and
then for 20 min at 651C in 0.1  SSC and 0.1% SDS solution.
Autoradiography was performed by exposing a Kodak X-Omat film
(Eastman Kodak Company, Rochester, New York) to the nitrocel-
lulose filters at 701C in the presence of an enhancing screen. The
cDNA probes for collagenase and 18S ribosomal RNA were ob-
tained from the American Type Culture Collection (Rockville, Mary-
land). The cDNA for human involucrin was a kind gift from Dr H.
Green (Howard Medical School, Department of Cell Biology, Bos-
ton, Massachusetts). The cDNA for the 14-3-3s protein was
obtained by extracting keratinocyte total RNA and amplified by
RT-PCR by a procedure described in the following sections.
Levels of KDAF in keratinocyte and ﬁbroblast-conditioned
media To determine whether the release of KDAF in conditioned
media is unique to keratinocytes, fibroblasts, or both, conditioned
media from either keratinocytes or fibroblasts were passed through
a Centricon filter with a 30 kDa cut-off. The corresponding filtrate
and retentate were collected and their volumes were adjusted to
the original volume used. Aliquots of whole conditioned medium
(C), filtrate (F), and retentate (R) were then used to treat dermal
fibroblasts for 24 h. Total RNA was then extracted individually and
the expression of collagenase mRNA was evaluated by northern
analysis as described in the previous section.
Preparation and efﬁcacy of recombinant 14-3-3r and KCM on
collagenase mRNA expression in dermal ﬁbroblasts The pro-
cedure of human recombinanat 14-3-3s protein preparation was
similar to that previously described (Ghahary et al, 2004). In gen-
eral, the expression of collagenase mRNA in dermal fibroblasts in
response to either KCM or our purified 14-3-3s was determined by
northern analsyis. To achieve this, three different experiments were
conducted. In the first set of experiments, keratinocytes were in-
itially cultured in KSFM (Gibco) supplemented with bovine pituitary
extract (50 mg per mL) and EGF (5 mg per mL). KCM was replaced
with our test medium and conditioned medium was collected every
48 h up to day 20. These media were then used to treat dermal
fibroblasts for another 24 h. Conditioned medium collected from
proliferating keratinocytes grown in KSFMþEGF and pituitary ex-
tract for 48 h was also used to treat fibroblasts for comparison.
Dermal fibroblasts that received fresh test medium with and with-
out 1.0 mg per mL 14-3-3s for the same duration were also in-
cluded as positive and negative controls, respectively. In a second
set of experiments, the efficacy of recombinant 14-3-3s on col-
lagenase mRNA expression in fibroblasts was evaluated by treat-
ing cells cultured in DMEM supplemented with 2% FBS with either
nothing or various concentrations (0.25, 0.5, 1.0, and 2.5 mg per
mL) of recombinant 14-3-3s for 24 h. In the third experimental
condition, cells were treated with either nothing or with 2.5 mg per
mL of 14-3-3s for 24 h and conditioned medium was then replaced
with fresh medium with no 14-3-3s. Cells were then harvested at 3,
6, 12, 24, 36, 48, and 72 after 14-3-3s removal. In these three
experimental conditions, cells were then harvested and the ex-
pression of collagenase mRNA was evaluated by northern analysis
according to the procedure described above. The same blots were
subsequently re-hybridized with a cDNA specific for 18S ribosomal
RNA and used as an RNA loading control.
Detection of intra- and extracellular levels of 14-3-3r protein by
western Blotting To evaluate the intra- and extracellular forms of
14-3-3s protein, conditioned medium collected from keratinocytes
(0.5  106 cells per well) grown in KSFM supplemented with BPE
and EGF for 48 h was replaced with test medium without FBS. FBS
was removed from test medium because serum proteins interferes
with electrophoresis of proteins present in conditioned medium.
KCM was then collected on day 0, 2, 4, 6, 8, and 10 and corre-
sponding cells were harvested. Conditioned medium was then
passed through a Centricon YM-3 filter device (Millipore) and levels
of the protein content of both cell extract and concentrated con-
ditioned medium were determined and an equal amount (50 mg per
sample) of total protein was subjected to SDS-PAGE analysis with
12% (wt/vol) acrylamide gel, and electrotransferred onto poly-
vinylidine difloride membranes (Millipore). Non-specific proteins on
membranes were blocked in 5% skim milk powder in PBS–0.1%
Tween-20 overnight. Immunoblotting was performed using 2 mg
per mL of goat anti-human 14-3-3s polyclonal antibody (Santa
Cruz Biotechnology, Santa Cruz, California), or 2 mg per mL of
mouse anti-human actin monoclonal antibody (Santa Cruz Bio-
technology). The membranes were then incubated with the appro-
priate secondary horseradish peroxidase-conjugated anti-goat IgG
(Sigma, St Louis, Missouri) or anti-mouse IgG (Jackson Immuno-
Research Laboratories, West Grove, Pennsylvania) antibodies
(1:2500 dilution). Immunoreactive proteins were then visualized
using the ECLþ Western blotting detection system (Amersham
Biosciences, Buckinghamshire, England).
Immunocytochemistry To perform immunohistochemical stain-
ing for stratifin and involucrin in cultured keratinocytes, 5  104
cells were grown in a wax circle drawn on glass slides (Snowcoat
X-tra, Surgipath, Richmond, Illinois) and left to attach overnight in
KSFMþBPEþEGF. The next day the slides were rinsed in PBS,
and the medium was switched to test medium to promote differ-
entiation. The medium was changed every 3 d. Cultured keratin-
ocytes were examined for their phase contrast appearance by a
Leica DBIRB microscope (Western Opti-Tech, San Francisco,
California). Cells were then photographed on day 5 and 9 using a
Spot Jr digital camera (Diagnostic Instruments, Heights, Michigan).
On each day of harvest, slides were washed with PBS, fixed for
10 min. in acetone, and left to air dry. For immunohistochemical
staining, the cultured keratinocytes were stained with a streptavi-
din–biotin immunoperoxidase procedure. For 14-3-3s staining,
slides were incubated overnight at 41C in a humidified chamber
with goat polyclonal anti-human 14-3-3s (0.4 mg per mL; Santa
Cruz), which is specific for stratifin. Control slides received non-
immune goat IgG (not shown). Biotinylated rabbit anti-goat (1:200,
DakoCytomation, Carpintena, California) was used as the second-
ary antibody. For involucrin staining, mouse monoclonal anti-in-
volucrin (1.6 mg per mL, Sigma) was used overnight using non-
immune mouse IgG (not shown) as a negative control. Biotinylated
goat anti-mouse (1:200, Vector Laboratories, Burlingame, Califor-
nia) was the secondary antibody. Detection was performed using
StreptABComplex/HRP (DakoCytomation), followed by incubation
in DAB. Slides were briefly counterstained in hematoxylin. Stained
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slides were examined using a Nikon Optiphot-2 microscope and
were photographed using a Nikon Coolpix 990 digital camera
(Nikon, Mississauga, ON, Canada). All digital images were analy-
zed using Quartz PCI, version 4 (Quartz Imaging, Vancouver, BC,
Canada). For details, the areas of multilayer and monolayer forming
keratinocytes from the low-magnification images were chosen as
insert rectangular and then photographed with higher magnifica-
tion.
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